EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Changes on the Board of Management

Bad Neustadt a. d. Saale, 18 October 2022

RHÖN-KLINIKUM AG: Changes on the Board of Management

The Chief Executive Officer of RHÖN-KLINIKUM AG, Dr. Christian Höftberger, asked the Chairman of the Supervisory Board of the company last week to terminate his contract ahead of schedule. Consequently, the Supervisory Board resolved today, in a meeting convened at short notice, to comply with this request. With this consensual step, both Dr. Christian Höftberger and the Supervisory Board would like to create room for new dynamics in the stalled negotiations between RHÖN-KLINIKUM AG and the State of Hesse on securing the future of the University Hospital Gießen and Marburg (UKGM) in the interests of the employees and all patients of UKGM.

As the new Chief Executive Officer of RHÖN-KLINIKUM AG, the Supervisory Board has appointed Prof. Dr. Tobias Kaltenbach, who will take office on 1 November 2022. In addition, the Supervisory Board has decided to reduce the size of the company's Board of Management to three members. Prof. Dr. Bernd Griewing will move in his function as CMO (Chief Medical Officer) to the position of a General Representative. As of 1 November 2022, the Board of Management will thus consist of Prof. Dr. Tobias Kaltenbach (CEO), Dr. Stefan Stranz (CFO) and Dr. Gunther K. Weiß (COO).

Contact:

RHÖN-KLINIKUM AG
Head of Investor Relations and Treasury
Julian Schmitt

T. +49 9771 65-12250 | [email protected]

RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale